About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Antisense and RNAi Therapeutics Market Size to Grow at a CAGR of 17.4% by 2032
Antisense and RNAi Therapeutics Market
Antisense and RNAi Therapeutics Market

Antisense and RNAi Therapeutics Market Size, Share & Trends Analysis Report By Technology (RNA Interference, siRNA, miRNA, Antisense RNA), By Application (Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Renal Diseases, Neurodegenerative Disorders, Genetic Disorders, Infectious Diseases, Others), By Route of Administration (Intravenous Route, Subcutaneous Route, Intrathecal Route, Pulmonary Delivery, Intraperitoneal Injection, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH56079DR
Last Updated : 06,May 2024
Author : Straits Research
Starting From
USD 995
Buy Now
File Formats
The sample report only takes 30 secs to download, no need to wait longer.

Market Segmentation

  1. Antisense and RNAi Therapeutics Market, By Technology (2020-2032)
    1. RNA Interference
    2. siRNA
    3. miRNA
    4. Antisense RNA
  2. Antisense and RNAi Therapeutics Market, By Application (2020-2032)
    1. Oncology
    2. Cardiovascular Diseases (CVDs)
    3. Respiratory Disorders
    4. Renal Diseases
    5. Neurodegenerative Disorders
    6. Genetic Disorders
    7. Infectious Diseases
    8. Others
  3. Antisense and RNAi Therapeutics Market, By Route of Administration (2020-2032)
    1. Intravenous Route
    2. Subcutaneous Route
    3. Intrathecal Route
    4. Pulmonary Delivery
    5. Intraperitoneal Injection
    6. Others
    1. North America
      1. North America Antisense and RNAi Therapeutics Market, By Technology
        1. RNA Interference
          1. siRNA
            1. miRNA
              1. Antisense RNA
              2. North America Antisense and RNAi Therapeutics Market, By Application
                1. Oncology
                  1. Cardiovascular Diseases (CVDs)
                    1. Respiratory Disorders
                      1. Renal Diseases
                        1. Neurodegenerative Disorders
                          1. Genetic Disorders
                            1. Infectious Diseases
                              1. Others
                              2. North America Antisense and RNAi Therapeutics Market, By Route of Administration
                                1. Intravenous Route
                                  1. Subcutaneous Route
                                    1. Intrathecal Route
                                      1. Pulmonary Delivery
                                        1. Intraperitoneal Injection
                                          1. Others
                                          2. U.S.
                                            1. U.S. Antisense and RNAi Therapeutics Market, By Technology
                                              1. RNA Interference
                                                1. siRNA
                                                  1. miRNA
                                                    1. Antisense RNA
                                                    2. U.S. Antisense and RNAi Therapeutics Market, By Application
                                                      1. Oncology
                                                        1. Cardiovascular Diseases (CVDs)
                                                          1. Respiratory Disorders
                                                            1. Renal Diseases
                                                              1. Neurodegenerative Disorders
                                                                1. Genetic Disorders
                                                                  1. Infectious Diseases
                                                                    1. Others
                                                                    2. U.S. Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                      1. Intravenous Route
                                                                        1. Subcutaneous Route
                                                                          1. Intrathecal Route
                                                                            1. Pulmonary Delivery
                                                                              1. Intraperitoneal Injection
                                                                                1. Others
                                                                              2. Canada
                                                                            2. Europe
                                                                              1. Europe Antisense and RNAi Therapeutics Market, By Technology
                                                                                1. RNA Interference
                                                                                  1. siRNA
                                                                                    1. miRNA
                                                                                      1. Antisense RNA
                                                                                      2. Europe Antisense and RNAi Therapeutics Market, By Application
                                                                                        1. Oncology
                                                                                          1. Cardiovascular Diseases (CVDs)
                                                                                            1. Respiratory Disorders
                                                                                              1. Renal Diseases
                                                                                                1. Neurodegenerative Disorders
                                                                                                  1. Genetic Disorders
                                                                                                    1. Infectious Diseases
                                                                                                      1. Others
                                                                                                      2. Europe Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                        1. Intravenous Route
                                                                                                          1. Subcutaneous Route
                                                                                                            1. Intrathecal Route
                                                                                                              1. Pulmonary Delivery
                                                                                                                1. Intraperitoneal Injection
                                                                                                                  1. Others
                                                                                                                  2. U.K.
                                                                                                                    1. U.K. Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                      1. RNA Interference
                                                                                                                        1. siRNA
                                                                                                                          1. miRNA
                                                                                                                            1. Antisense RNA
                                                                                                                            2. U.K. Antisense and RNAi Therapeutics Market, By Application
                                                                                                                              1. Oncology
                                                                                                                                1. Cardiovascular Diseases (CVDs)
                                                                                                                                  1. Respiratory Disorders
                                                                                                                                    1. Renal Diseases
                                                                                                                                      1. Neurodegenerative Disorders
                                                                                                                                        1. Genetic Disorders
                                                                                                                                          1. Infectious Diseases
                                                                                                                                            1. Others
                                                                                                                                            2. U.K. Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                              1. Intravenous Route
                                                                                                                                                1. Subcutaneous Route
                                                                                                                                                  1. Intrathecal Route
                                                                                                                                                    1. Pulmonary Delivery
                                                                                                                                                      1. Intraperitoneal Injection
                                                                                                                                                        1. Others
                                                                                                                                                      2. Germany
                                                                                                                                                      3. France
                                                                                                                                                      4. Spain
                                                                                                                                                      5. Italy
                                                                                                                                                      6. Russia
                                                                                                                                                      7. Nordic
                                                                                                                                                      8. Benelux
                                                                                                                                                      9. Rest of Europe
                                                                                                                                                    2. APAC
                                                                                                                                                      1. APAC Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                        1. RNA Interference
                                                                                                                                                          1. siRNA
                                                                                                                                                            1. miRNA
                                                                                                                                                              1. Antisense RNA
                                                                                                                                                              2. APAC Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                1. Oncology
                                                                                                                                                                  1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                    1. Respiratory Disorders
                                                                                                                                                                      1. Renal Diseases
                                                                                                                                                                        1. Neurodegenerative Disorders
                                                                                                                                                                          1. Genetic Disorders
                                                                                                                                                                            1. Infectious Diseases
                                                                                                                                                                              1. Others
                                                                                                                                                                              2. APAC Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                1. Intravenous Route
                                                                                                                                                                                  1. Subcutaneous Route
                                                                                                                                                                                    1. Intrathecal Route
                                                                                                                                                                                      1. Pulmonary Delivery
                                                                                                                                                                                        1. Intraperitoneal Injection
                                                                                                                                                                                          1. Others
                                                                                                                                                                                          2. China
                                                                                                                                                                                            1. China Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                              1. RNA Interference
                                                                                                                                                                                                1. siRNA
                                                                                                                                                                                                  1. miRNA
                                                                                                                                                                                                    1. Antisense RNA
                                                                                                                                                                                                    2. China Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                      1. Oncology
                                                                                                                                                                                                        1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                          1. Respiratory Disorders
                                                                                                                                                                                                            1. Renal Diseases
                                                                                                                                                                                                              1. Neurodegenerative Disorders
                                                                                                                                                                                                                1. Genetic Disorders
                                                                                                                                                                                                                  1. Infectious Diseases
                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                    2. China Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                      1. Intravenous Route
                                                                                                                                                                                                                        1. Subcutaneous Route
                                                                                                                                                                                                                          1. Intrathecal Route
                                                                                                                                                                                                                            1. Pulmonary Delivery
                                                                                                                                                                                                                              1. Intraperitoneal Injection
                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                              2. Korea
                                                                                                                                                                                                                              3. Japan
                                                                                                                                                                                                                              4. India
                                                                                                                                                                                                                              5. Australia
                                                                                                                                                                                                                              6. Singapore
                                                                                                                                                                                                                              7. Taiwan
                                                                                                                                                                                                                              8. South East Asia
                                                                                                                                                                                                                              9. Rest of Asia-Pacific
                                                                                                                                                                                                                            2. Middle East and Africa
                                                                                                                                                                                                                              1. Middle East and Africa Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                1. RNA Interference
                                                                                                                                                                                                                                  1. siRNA
                                                                                                                                                                                                                                    1. miRNA
                                                                                                                                                                                                                                      1. Antisense RNA
                                                                                                                                                                                                                                      2. Middle East and Africa Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                        1. Oncology
                                                                                                                                                                                                                                          1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                            1. Respiratory Disorders
                                                                                                                                                                                                                                              1. Renal Diseases
                                                                                                                                                                                                                                                1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                  1. Genetic Disorders
                                                                                                                                                                                                                                                    1. Infectious Diseases
                                                                                                                                                                                                                                                      1. Others
                                                                                                                                                                                                                                                      2. Middle East and Africa Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                        1. Intravenous Route
                                                                                                                                                                                                                                                          1. Subcutaneous Route
                                                                                                                                                                                                                                                            1. Intrathecal Route
                                                                                                                                                                                                                                                              1. Pulmonary Delivery
                                                                                                                                                                                                                                                                1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                  1. Others
                                                                                                                                                                                                                                                                  2. UAE
                                                                                                                                                                                                                                                                    1. UAE Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                      1. RNA Interference
                                                                                                                                                                                                                                                                        1. siRNA
                                                                                                                                                                                                                                                                          1. miRNA
                                                                                                                                                                                                                                                                            1. Antisense RNA
                                                                                                                                                                                                                                                                            2. UAE Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                              1. Oncology
                                                                                                                                                                                                                                                                                1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                  1. Respiratory Disorders
                                                                                                                                                                                                                                                                                    1. Renal Diseases
                                                                                                                                                                                                                                                                                      1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                        1. Genetic Disorders
                                                                                                                                                                                                                                                                                          1. Infectious Diseases
                                                                                                                                                                                                                                                                                            1. Others
                                                                                                                                                                                                                                                                                            2. UAE Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                              1. Intravenous Route
                                                                                                                                                                                                                                                                                                1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                  1. Intrathecal Route
                                                                                                                                                                                                                                                                                                    1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                      1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                        1. Others
                                                                                                                                                                                                                                                                                                      2. Turkey
                                                                                                                                                                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                                                                                                                                                                      4. South Africa
                                                                                                                                                                                                                                                                                                      5. Egypt
                                                                                                                                                                                                                                                                                                      6. Nigeria
                                                                                                                                                                                                                                                                                                      7. Rest of MEA
                                                                                                                                                                                                                                                                                                    2. LATAM
                                                                                                                                                                                                                                                                                                      1. LATAM Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                                                        1. RNA Interference
                                                                                                                                                                                                                                                                                                          1. siRNA
                                                                                                                                                                                                                                                                                                            1. miRNA
                                                                                                                                                                                                                                                                                                              1. Antisense RNA
                                                                                                                                                                                                                                                                                                              2. LATAM Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                1. Oncology
                                                                                                                                                                                                                                                                                                                  1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                                                    1. Respiratory Disorders
                                                                                                                                                                                                                                                                                                                      1. Renal Diseases
                                                                                                                                                                                                                                                                                                                        1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                                                          1. Genetic Disorders
                                                                                                                                                                                                                                                                                                                            1. Infectious Diseases
                                                                                                                                                                                                                                                                                                                              1. Others
                                                                                                                                                                                                                                                                                                                              2. LATAM Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                1. Intravenous Route
                                                                                                                                                                                                                                                                                                                                  1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                                                    1. Intrathecal Route
                                                                                                                                                                                                                                                                                                                                      1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                                                        1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                                                          1. Others
                                                                                                                                                                                                                                                                                                                                          2. Brazil
                                                                                                                                                                                                                                                                                                                                            1. Brazil Antisense and RNAi Therapeutics Market, By Technology
                                                                                                                                                                                                                                                                                                                                              1. RNA Interference
                                                                                                                                                                                                                                                                                                                                                1. siRNA
                                                                                                                                                                                                                                                                                                                                                  1. miRNA
                                                                                                                                                                                                                                                                                                                                                    1. Antisense RNA
                                                                                                                                                                                                                                                                                                                                                    2. Brazil Antisense and RNAi Therapeutics Market, By Application
                                                                                                                                                                                                                                                                                                                                                      1. Oncology
                                                                                                                                                                                                                                                                                                                                                        1. Cardiovascular Diseases (CVDs)
                                                                                                                                                                                                                                                                                                                                                          1. Respiratory Disorders
                                                                                                                                                                                                                                                                                                                                                            1. Renal Diseases
                                                                                                                                                                                                                                                                                                                                                              1. Neurodegenerative Disorders
                                                                                                                                                                                                                                                                                                                                                                1. Genetic Disorders
                                                                                                                                                                                                                                                                                                                                                                  1. Infectious Diseases
                                                                                                                                                                                                                                                                                                                                                                    1. Others
                                                                                                                                                                                                                                                                                                                                                                    2. Brazil Antisense and RNAi Therapeutics Market, By Route of Administration
                                                                                                                                                                                                                                                                                                                                                                      1. Intravenous Route
                                                                                                                                                                                                                                                                                                                                                                        1. Subcutaneous Route
                                                                                                                                                                                                                                                                                                                                                                          1. Intrathecal Route
                                                                                                                                                                                                                                                                                                                                                                            1. Pulmonary Delivery
                                                                                                                                                                                                                                                                                                                                                                              1. Intraperitoneal Injection
                                                                                                                                                                                                                                                                                                                                                                                1. Others
                                                                                                                                                                                                                                                                                                                                                                              2. Mexico
                                                                                                                                                                                                                                                                                                                                                                              3. Argentina
                                                                                                                                                                                                                                                                                                                                                                              4. Chile
                                                                                                                                                                                                                                                                                                                                                                              5. Colombia
                                                                                                                                                                                                                                                                                                                                                                              6. Rest of LATAM

                                                                                                                                                                                                                                                                                                                                                                          Related Reports

                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global bispecific antibodies market size was valued at USD 8.2 billion in 2023 and is projected to reach a value of USD 224.6 billion by 2032, registering a CAGR of 44.4% during the forecast period (2024-2032). The rise in cancer incidence is a c
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global X-Ray Inspection System Market size was valued at USD 734.5 Million in 2022 and is projected to reach USD 1231.3 Million by 2031, registering a CAGR of 6.6% during the forecast period (2023-2031). The rising awareness of the bene
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          Inflight Catering Market Size and Trends The global inflight catering market size was valued at USD 13.62 billion in 2023. It is projected to reach from USD 15.16 billion in 2024 to USD 35.75 billion by 2032, growing at a CAGR of 11.32% during the f
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global bladder scanners market size was valued at USD 141.70 million in 2022. It is projected to reach USD 232.38 million by 2031, growing at a CAGR of 5.65% during the forecast period (2023-2031). This is because many people globally have u
                                                                                                                                                                                                                                                                                                                                                                          Buy Now
                                                                                                                                                                                                                                                                                                                                                                          Global Report
                                                                                                                                                                                                                                                                                                                                                                          The global hair removal wax market size was valued at USD 13,110 million in 2022. It is estimated to reach USD 20,228 million by 2031, growing at a CAGR of 4.9% during the forecast period (2023–2031). Highlights Soft wax
                                                                                                                                                                                                                                                                                                                                                                          Buy Now

                                                                                                                                                                                                                                                                                                                                                                          Purchase Benefits

                                                                                                                                                                                                                                                                                                                                                                          • Eligible for a free updated report next year
                                                                                                                                                                                                                                                                                                                                                                          • Completely customizable scope
                                                                                                                                                                                                                                                                                                                                                                          • 30% discount on your next purchase
                                                                                                                                                                                                                                                                                                                                                                          • Dedicated account manager
                                                                                                                                                                                                                                                                                                                                                                          • Query resolution within 24 hours
                                                                                                                                                                                                                                                                                                                                                                          • Permission to print the report

                                                                                                                                                                                                                                                                                                                                                                          We are featured on :

                                                                                                                                                                                                                                                                                                                                                                          www.straitsresearch.com
                                                                                                                                                                                                                                                                                                                                                                          © Copyright . All rights Reserved.